Nav: Home

Stroke patients take the lead in their rehabilitation

May 09, 2017

Every year, 17 million people worldwide suffer strokes, and a third are left paralyzed on one side of their body. But current rehabilitation solutions are not always effective in improving mobility declines after the first few months. This is where EPFL startup Intento comes in with a new device that can help patients regain mobility in their arms. Lausanne University Hospital (CHUV) conducted a clinical study on the device and has now published the encouraging results in Archives of Physical Medicine and Rehabilitation.

One common stroke-rehabilitation method used today is functional electrical stimulation: the therapist places electrodes on the patient's skin, adjusts the stimulus intensity, and delivers an electrical shock that makes the patient's muscles move. However, studies have shown that this therapy works better when the patients are actively involved in moving their own limbs.

Intento leveraged the benefits of self-regulating electrical pulses to develop a system that lets the patient take the lead in rehabilitation their arms. With Intento's device, patients self-administer the electrical stimulation to generate the desired motor functions and perform basic tasks. Even severely paralyzed patients can use the new system to regain control of an arm and work towards a more active therapy.

Intento's system consists of electrode patches, a device the patients control using their working hand, and tablet software also developed by Intento. The therapist selects one of several programmed movements on the tablet and loads it, with a single click, onto the device. The program shows where the electrodes need to be placed and automatically configures the electrical pulse settings to generate the desired movement. Patients then move their functioning hand to control the electrical stimulation needed to, for example, pick up a glass or press a button. The ultimate aim is that, after a number of repetitions, patients can perform the movements without using the device.

Improved mobility in 70% of patients

The CHUV ran a clinical study to compare Intento's device to conventional occupational therapy. Eleven severely paralyzed patients who had suffered a stroke more than six months prior to the study and for whom other therapies had not worked underwent 1.5-hour sessions of the new treatment over 10 days. The results were then compared to their mobility following conventional occupational therapy over the same amount of time. The patients' mobility was measured before and after each type of treatment.

The study showed that patients' mobility significantly improved with Intento's device. Intento's co-founder Andrea Biasiucci said that 70% of patients showed a significant improvement in their motor functions, versus only 30% with the conventional therapy. Andrea Maesani, Intento's CEO and other cofounder, said: "Above and beyond the study's findings, several of the patients told us a few weeks later that they were already using their arms more than before." Patients were still making steady progress six months after the study was conducted, suggesting that the treatment produces long-term effects. Intento's two founders are now going to run a clinical study on a larger group before marketing their device.
-end-


Ecole Polytechnique Fédérale de Lausanne

Related Stroke Articles:

Retraining the brain to see after stroke
A new study out today in Neurology, provides the first evidence that rigorous visual training restores rudimentary sight in patients who went partially blind after suffering a stroke, while patients who did not train continued to get progressively worse.
Catheter ablations reduce risks of stroke in heart patients with stroke history, study finds
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation to treat the abnormal heart rhythm lower their long-term risk of a recurrent stroke by 50 percent, according to new research from the Intermountain Medical Center Heart Institute.
Imaging stroke risk in 4-D
A new MRI technique developed at Northwestern University detects blood flow velocity to identify who is most at risk for stroke, so they can be treated accordingly.
Biomarkers may help better predict who will have a stroke
People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the Aug.
Pre-stroke risk factors influence long-term future stroke, dementia risk
If you had heart disease risk factors, such as high blood pressure, before your first stoke, your risk of suffering subsequent strokes and dementia long after your initial stroke may be higher.
More Stroke News and Stroke Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...